- Home
- IHS vs RLAY Comparison
IHS vs RLAY Comparison
Compare IHS & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHS
- RLAY
- Stock Information
- Founded
- IHS 2001
- RLAY 2015
- Country
- IHS United Kingdom
- RLAY United States
- Employees
- IHS N/A
- RLAY N/A
- Industry
- IHS Telecommunications Equipment
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IHS Telecommunications
- RLAY Health Care
- Exchange
- IHS Nasdaq
- RLAY Nasdaq
- Market Cap
- IHS 979.2M
- RLAY 1.1B
- IPO Year
- IHS 2021
- RLAY 2020
- Fundamental
- Price
- IHS $2.98
- RLAY $4.79
- Analyst Decision
- IHS Strong Buy
- RLAY Strong Buy
- Analyst Count
- IHS 7
- RLAY 9
- Target Price
- IHS $9.07
- RLAY $20.88
- AVG Volume (30 Days)
- IHS 375.9K
- RLAY 1.6M
- Earning Date
- IHS 11-12-2024
- RLAY 11-06-2024
- Dividend Yield
- IHS N/A
- RLAY N/A
- EPS Growth
- IHS N/A
- RLAY N/A
- EPS
- IHS N/A
- RLAY N/A
- Revenue
- IHS $1,783,187,000.00
- RLAY $10,006,000.00
- Revenue This Year
- IHS N/A
- RLAY N/A
- Revenue Next Year
- IHS $2.40
- RLAY N/A
- P/E Ratio
- IHS N/A
- RLAY N/A
- Revenue Growth
- IHS N/A
- RLAY N/A
- 52 Week Low
- IHS $2.18
- RLAY $4.48
- 52 Week High
- IHS $5.28
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- IHS 56.83
- RLAY 23.64
- Support Level
- IHS $2.71
- RLAY $5.96
- Resistance Level
- IHS $2.94
- RLAY $6.39
- Average True Range (ATR)
- IHS 0.17
- RLAY 0.34
- MACD
- IHS 0.03
- RLAY -0.12
- Stochastic Oscillator
- IHS 92.24
- RLAY 7.92
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).